RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)

Clinical Trial Grant

Duke Scholars

Principal Investigator John Strickler Medicine, Medical Oncology

Awarded By

Revolution Medicines, Inc

Start Date

November 14, 2024

End Date

November 26, 2029

Awarded By

Revolution Medicines, Inc

Start Date

November 14, 2024

End Date

November 26, 2029